SCHEMBL23679179

SCHEMBL23679179

CNCCC(Nc1nc2ccccc2[nH]1)c1cccc(C(F)(F)F)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC6A2 P23975 3/20 0.47
▸ SLC6A4 P31645 3/20 0.47
▸ ITGA5 P08648 1/20 0.44
▸ ITGB6 P18564 1/20 0.44
▸ ITGB8 P26012 1/20 0.44
▸ MTOR P42345 1/20 0.40
▸ CYP2D6 P10635 2/20 0.39
▸ NOS2 P35228 2/20 0.39
▸ BCHE P06276 1/20 0.39
▸ TRPC3 Q13507 1/20 0.39
▸ TRPC4 Q9UBN4 1/20 0.39
▸ TRPC5 Q9UL62 1/20 0.39
▸ PKM P14618 1/20 0.38
▸ NPC1 O15118 1/20 0.38
▸ HTT P42858 1/20 0.38
▸ RAB9A P51151 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ NTRK1 P04629 1/20 0.38
▸ NTRK2 Q16620 1/20 0.38
▸ TEAD4 Q15561 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20764688 0.87 ITGA5 (0.46) ITGA5ITGB6ITGB8MTORBCHE
SCHEMBL30410775 0.87 ITGA5 (0.46) ITGA5ITGB6ITGB8MTORBCHE
SCHEMBL30645125 0.86 ITGA5 (0.44) ITGA5ITGB6ITGB8MTORNPC1
SCHEMBL22188672 0.86 ITGA5 (0.44) ITGA5ITGB6ITGB8MTORNPC1
SCHEMBL20743024 0.86 ITGA5 (0.45) ITGA5ITGB6ITGB8MTORNPC1
SCHEMBL20764702 0.85 ITGA5 (0.46) ITGA5ITGB6ITGB8MTORBCHE
SCHEMBL19283611 0.85 ITGA5 (0.46) ITGA5ITGB6ITGB8MTORNPC1
SCHEMBL20792208 0.85 PNMT (0.47) ITGA5ITGB6ITGB8MTORNPC1
SCHEMBL20743289 0.84 ITGA5 (0.45) ITGA5ITGB6ITGB8MTORPKM
Hydrochloric Acid SCHEMBL22321392 0.84 PNMT (0.46) ITGA5ITGB6ITGB8MTORNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3672953-B1 BENZIMIDAZOLE DERIVATIVES USEFUL AS POTASSIUM CHANNEL INHIBITORS ACESION PHARMA APS (DK) 2021-07-28 — — EP disclosed
Send feedback